Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Barbara Belletti & Gustavo Baldassarre. (2011) Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opinion on Therapeutic Targets 15:11, pages 1249-1266.
Read now
Read now
Zahra Bahrani-Mostafavi, Timothy L. Tickle, Jian Zhang, Kristen E. Bennett, Judith C. Vachris, Melanie D. Spencer, M. Taghi Mostafavi & David L. Tait. (2008) Correlation Analysis of HOX, ErbB and IGFBP Family Gene Expression in Ovarian Cancer. Cancer Investigation 26:10, pages 990-998.
Read now
Read now
Articles from other publishers (54)
Ruiqi Liu, Xiaodong Liang, Haiwei Guo, Shuang Li, Weiping Yao, Chenfang Dong, Jiajun Wu, Yanwei Lu, Jianming Tang & Haibo Zhang. (2023) STNM1 in human cancers: role, function and potential therapy sensitizer. Cellular Signalling 109, pages 110775.
Crossref
Crossref
Mana Azumi, Mikihiro Yoshie, Nami Nakachi, Atsuya Tsuru, Kazuya Kusama & Kazuhiro Tamura. (2022) Stathmin expression alters the antiproliferative effect of eribulin in leiomyosarcoma cells. Journal of Pharmacological Sciences 150:4, pages 259-266.
Crossref
Crossref
Mana Azumi, Mikihiro Yoshie, Wataru Takano, Akari Ishida, Kazuya Kusama & Kazuhiro Tamura. (2022) The Impact of Eribulin on Stathmin Dynamics and Paclitaxel Sensitivity in Ovarian Cancer Cells. Biological and Pharmaceutical Bulletin 45:11, pages 1627-1635.
Crossref
Crossref
Gaddam Deepthi, Purnima Vadla, Vaishnavi Julakanti, Divya Jahagirdar, Swetha Meruva & Swapnika Tantravahi. (2022) Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression. The Journal of Contemporary Dental Practice 23:5, pages 497-502.
Crossref
Crossref
Lekai Nie, Chen Zhang, Haiyun Song, Qianqian Zhao, Lei Cheng, Peihai Zhang & Xingsheng Yang. (2022) Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer. Disease Markers 2022, pages 1-15.
Crossref
Crossref
Sofia Liou, Neshat Nilforoushan, Yuna Kang & Neda A. Moatamed. (2021) p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia. Diagnostic Pathology 16:1.
Crossref
Crossref
Mikihiro Yoshie, Akari Ishida, Haruka Ohashi, Nami Nakachi, Mana Azumi & Kazuhiro Tamura. (2021) Stathmin dynamics modulate the activity of eribulin in breast cancer cells. Pharmacology Research & Perspectives 9:4.
Crossref
Crossref
Valentino Clemente, Asumi Hoshino, Joyce Meints, Mihir Shetty, Tim Starr, Michael Lee & Martina Bazzaro. (2021) UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System. Cells 10:7, pages 1604.
Crossref
Crossref
Filip Borys, Ewa Joachimiak, Hanna Krawczyk & Hanna Fabczak. (2020) Intrinsic and Extrinsic Factors Affecting Microtubule Dynamics in Normal and Cancer Cells. Molecules 25:16, pages 3705.
Crossref
Crossref
Kuldeep Giri, Anurag Mehta & Kiran Ambatipudi. (2019) In search of the altering salivary proteome in metastatic breast and ovarian cancers. FASEB BioAdvances 1:3, pages 191-207.
Crossref
Crossref
Yifei Ma, Ting Liu, Xiue Song, Yuling Tian, Yongqing Wei, Jidong Wang, Xiao Li & Xingsheng Yang. (2017) Siva 1 inhibits proliferation, migration and invasion by phosphorylating Stathmin in ovarian cancer cells. Oncology Letters 14:2, pages 1512-1518.
Crossref
Crossref
Huiliang Yang, Wayne Bond Lau, Bonnie Lau, Yu Xuan, Shengtao Zhou, Linjie Zhao, Zhongyue Luo, Qiao Lin, Ning Ren, Xia Zhao & Yuquan Wei. (2017) A mass spectrometric insight into the origins of benign gynecological disorders. Mass Spectrometry Reviews 36:3, pages 450-470.
Crossref
Crossref
Yun-De Dou, Han Zhao, Tao Huang, Shi-Gang Zhao, Xiao-Man Liu, Xiao-Chen Yu, Zeng-Xiang Ma, Yu-Chao Zhang, Tao Liu, Xuan Gao, Lei Li, Gang Lu, Wai-Yee Chan, Fei Gao, Hong-Bin Liu & Zi-Jiang Chen. (2016) STMN1 Promotes Progesterone Production Via StAR Up-regulation in Mouse Granulosa Cells. Scientific Reports 6:1.
Crossref
Crossref
Soazig Malesinski, Philipp O. Tsvetkov, Anna Kruczynski, Vincent Peyrot & François Devred. (2015) Stathmin Potentiates Vinflunine and Inhibits Paclitaxel Activity. PLOS ONE 10:6, pages e0128704.
Crossref
Crossref
Marie-Claire Maroun, Ofelia Olivero, Leonard Lipovich, Azadeh Stark, Larry Tait, Sudeshna Bandyopadhyay, Matthew Burke, Richard Zarbo, Dhananjay Chitale, S. David Nathanson, Mike Long, Carol Peebles & Félix Fernández Madrid. (2014) Anti-centrosome antibodies in breast cancer are the expression of autoimmunity. Immunologic Research 60:2-3, pages 339-347.
Crossref
Crossref
Suliman A. Alsagaby, Sanjay Khanna, Keith W. Hart, Guy Pratt, Christopher Fegan, Christopher Pepper, Ian A. Brewis & Paul Brennan. (2014) Proteomics-Based Strategies To Identify Proteins Relevant to Chronic Lymphocytic Leukemia. Journal of Proteome Research 13:11, pages 5051-5062.
Crossref
Crossref
C Miceli, A Tejada, A Castaneda & S J Mistry. (2013) Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer. Cancer Gene Therapy 20:5, pages 298-307.
Crossref
Crossref
Paola Indovina, Eleonora Marcelli, Francesca Pentimalli, Piero Tanganelli, Giulio Tarro & Antonio Giordano. (2013) Mass spectrometry-based proteomics: The road to lung cancer biomarker discovery. Mass Spectrometry Reviews 32:2, pages 129-142.
Crossref
Crossref
Brooke E. Howitt, Marisa R. Nucci, Ronny Drapkin, Christopher P. Crum & Michelle S. Hirsch. (2013) Stathmin-1 Expression as a Complement to p16 Helps Identify High-grade Cervical Intraepithelial Neoplasia With Increased Specificity. American Journal of Surgical Pathology 37:1, pages 89-97.
Crossref
Crossref
Xuechi Lin, Min Tang, Yongguang Tao, Lili Li, Sufang Liu, Lili Guo, Zijian Li, Xiaoqian Ma, Juan Xu & Ya Cao. (2012)
E
pstein–
B
arr virus‐encoded
LMP
1 triggers regulation of the
ERK
‐mediated
O
p18/stathmin signaling pathway in association with cell cycle
. Cancer Science 103:6, pages 993-999.
Crossref
Crossref
Bruce K. Carney, Victoria Caruso Silva & Lynne Cassimeris. (2012) The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53. Cytoskeleton 69:5, pages 278-289.
Crossref
Crossref
Dominic Chi Hiung Ng & Frances Byrne. 2012. Cytoskeleton and Human Disease. Cytoskeleton and Human Disease
259
284
.
Manimalha Balasubramani, Chitose Nakao, Guy T. Uechi, John Cardamone, Kathy Kamath, Kristen L. Leslie, Raghavan Balachandran, Leslie Wilson, Billy W. Day & Mary Ann Jordan. (2011) Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 722:2, pages 154-164.
Crossref
Crossref
Feng Wang, Liu‐Xing Wang, Sheng‐Lei Li, Ke Li, Wei He, Hong‐Tao Liu & Qing‐Xia Fan. (2011) Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma. Journal of Surgical Oncology 103:7, pages 704-715.
Crossref
Crossref
Zhanjun Lu, Aijian Qin, Kun Qian, Xinhong Chen, Wenjie Jin, Yufeng Zhu & Y.M. Eltahir. (2010) Proteomic analysis of the host response in the bursa of Fabricius of chickens infected with Marek's disease virus. Virus Research 153:2, pages 250-257.
Crossref
Crossref
Taia Maria Berto Rezende, Mirna de Souza Freire & Octávio Luiz Franco. (2010) Head and neck cancer. Cancer 116:21, pages 4914-4925.
Crossref
Crossref
Si-Guang Xu, Pei-Jun Yan & Zhi-Ming Shao. (2010) Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis. Journal of Cancer Research and Clinical Oncology 136:10, pages 1545-1556.
Crossref
Crossref
Cong Wang, Shaoqiang Lin, Yanfang Nie, Xinglong Jia, Jing Wang, Jian Xiao, Jianzhang Wu, Xiaokun Li & Xiaoping Wu. (2010) Mechanism of antitumor effect of a novel bFGF binding peptide on human colon cancer cells. Cancer Science 101:5, pages 1212-1218.
Crossref
Crossref
François Devred, Pascale Barbier, Daniel Lafitte, Isabelle Landrieu, Guy Lippens & Vincent Peyrot. 2010. Microtubules, in vitro. Microtubules, in vitro
449
480
.
Wang Xi, Wang Rui, Lin Fang, Dong Ke, Gao Ping & Zhang Hui-Zhong. (2008) Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients. Journal of Cancer Research and Clinical Oncology 135:6, pages 837-846.
Crossref
Crossref
Zhen Cai, Yuan Zhou, Ting Lei, Jen‐Fu Chiu & Qing‐Yu He. (2008) Mammary serine protease inhibitor inhibits epithelial growth factor‐induced epithelial‐mesenchymal transition of esophageal carcinoma cells. Cancer 115:1, pages 36-48.
Crossref
Crossref
Rohit G. Saldanha, Ning Xu, Mark P. Molloy, Duncan A. Veal & Mark S. Baker. (2008) Differential Proteome Expression Associated with Urokinase Plasminogen Activator Receptor (uPAR) Suppression in Malignant Epithelial Cancer. Journal of Proteome Research 7:11, pages 4792-4806.
Crossref
Crossref
Francois Devred, Philipp O. Tsvetkov, Pascale Barbier, Diane Allegro, Susan Band Horwitz, Alexander A. Makarov & Vincent Peyrot. (2008) Stathmin/Op18 is a novel mediator of vinblastine activity. FEBS Letters 582:17, pages 2484-2488.
Crossref
Crossref
Barbara BellettiMilena S. NicolosoMonica SchiappacassiStefania BertonFrancesca LovatKatarina Wolf, Vincenzo Canzonieri, Sara D'AndreaAntonella ZucchettoPeter Friedl, Alfonso Colombatti & Gustavo Baldassarre. (2008) Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential. Molecular Biology of the Cell 19:5, pages 2003-2013.
Crossref
Crossref
Hiroshi KOGO, Mikihiro YOSHIE, Masahiko KUTSUKAKE & Kazuhiro TAMURA. (2008) Roles of Implantation-related Factors, Stathmin and Insuline-like Growth Factor-binding Protein 7 in Reproductive Endocrinology着床関連因子として同定されたスタスミンとインスリン様増殖因子低親和性結合タンパク質 Insuline-like growth factor-binding protein 7の生殖内分泌学的意義. YAKUGAKU ZASSHI 128:4, pages 565-574.
Crossref
Crossref
Gene J. Ahlborn, Gail M. Nelson, William O. Ward, Geremy Knapp, James W. Allen, Ming Ouyang, Barbara C. Roop, Yan Chen, Thomas O'Brien, Kirk T. Kitchin & Don A. Delker. (2008) Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite. Toxicology and Applied Pharmacology 227:3, pages 400-416.
Crossref
Crossref
San-Hua Wei, Fang Lin, Xi Wang, Ping Gao & Hui-Zhong Zhang. (2008) Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma. Acta Histochemica 110:1, pages 59-65.
Crossref
Crossref
Rui Wang, Ke Dong, Fang Lin, Xi Wang, Ping Gao, San-Hua Wei, Shi-Yin Cheng & Hui-Zhong Zhang. (2007) Inhibiting Proliferation and Enhancing Chemosensitivity to Taxanes in Osteosarcoma Cells by RNA Interference-Mediated Downregulation of Stathmin Expression. Molecular Medicine 13:11-12, pages 567-575.
Crossref
Crossref
Hai-yang XIE, Wei-liang XIA, Chun-chao ZHANG, Li-ming WU, Hao-feng JI, Yu CHENG & Shu-sen ZHENG. (2007) Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Acta Pharmacologica Sinica 28:7, pages 975-984.
Crossref
Crossref
Ritwik Ghosh, Guangyu Gu, Erin Tillman, Jialing Yuan, Yongqing Wang, Ladan Fazli, Paul S. Rennie & Susan Kasper. (2007) Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. The Prostate 67:10, pages 1038-1052.
Crossref
Crossref
Elizabeth Alli, Jin-Ming Yang, James M. Ford & William N. Hait. (2007) Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells. Molecular Pharmacology 71:5, pages 1233-1240.
Crossref
Crossref
E Alli, J-M Yang & W N Hait. (2006) Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26:7, pages 1003-1012.
Crossref
Crossref
Kazuhiro Tamura, Mikihiro Yoshie, Hirotaka Nishi, Yumi Osakabe, Keiichi Isaka, Takahiko Hara & Hiroshi Kogo. (2006) Expression of stathmin in human uterus and decidualizing endometrial stromal cells. Reproduction 132:4, pages 625-636.
Crossref
Crossref
R‐H Yuan, Y‐M Jeng, H‐L Chen, P‐L Lai, H‐W Pan, F‐J Hsieh, C‐Y Lin, P‐H Lee & H‐C Hsu. (2006)
Stathmin overexpression cooperates with
p53
mutation and
osteopontin
overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma
. The Journal of Pathology 209:4, pages 549-558.
Crossref
Crossref
Heun-Sik Lee, Dong Chul Lee, Mee-Hee Park, Suk-Jin Yang, Jung Ju Lee, Dong Min Kim, Yejin Jang, Jae-Hyuck Lee, Jong Young Choi, Yun Kyung Kang, Dae Il Kim, Kyung Chan Park, Seon-Young Kim, Hyang-Sook Yoo, Eui-Ju Choi & Young Il Yeom. (2006) STMN2 is a novel target of β-catenin/TCF-mediated transcription in human hepatoma cells. Biochemical and Biophysical Research Communications 345:3, pages 1059-1067.
Crossref
Crossref
Y Kouzu, K Uzawa, H Koike, K Saito, D Nakashima, M Higo, Y Endo, A Kasamatsu, M Shiiba, H Bukawa, H Yokoe & H Tanzawa. (2006) Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. British Journal of Cancer 94:5, pages 717-723.
Crossref
Crossref
Dai Nakashima, Katsuhiro Uzawa, Atsushi Kasamatsu, Hirofumi Koike, Yosuke Endo, Kengo Saito, Susumu Hashitani, Tsutomu Numata, Masahiro Urade & Hideki Tanzawa. (2006) Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands. International Journal of Cancer 118:3, pages 704-713.
Crossref
Crossref
Sucharita J. Mistry, Alexander Bank & George F. Atweh. (2005) Targeting stathmin in prostate cancer. Molecular Cancer Therapeutics 4:12, pages 1821-1829.
Crossref
Crossref
Pei-Zhou JIANG, Ming GAN, Hua HUANG, Xin-Ming SHEN, Shuang WANG & Kai-Tai YAO. (2005) Proteomics-based Identification of Proteins with Altered Expression Induced by 12-O-Tetradecanoylphorbol 13-acetate in Nasopharyngeal Carcinoma CNE2 Cells. Acta Biochimica et Biophysica Sinica 37:2, pages 97-106.
Crossref
Crossref
Sima Don, Nicole M. Verrills, Tracy Y.E. Liaw, Marjorie L.M. Liu, Murray D. Norris, Michelle Haber & Maria Kavallaris. (2004) Neuronal-associated microtubule proteins class III β-tubulin and MAP2c in neuroblastoma: Role in resistance to microtubule-targeted drugs. Molecular Cancer Therapeutics 3:9, pages 1137-1146.
Crossref
Crossref
Haixing Wang, Maureen T. Kachman, Donald R. Schwartz, Kathleen R. Cho & David M. Lubman. (2004) Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: A strategy for identification of candidate cancer biomarkers. PROTEOMICS 4:8, pages 2476-2495.
Crossref
Crossref
Raghavan Balachandran, Manda J Welsh & Billy W Day. (2003) Altered levels and regulation of stathmin in paclitaxel-resistant ovarian cancer cells. Oncogene 22:55, pages 8924-8930.
Crossref
Crossref
Guoan Chen, Hong Wang, Tarek G. Gharib, Chiang-Ching Huang, Dafydd G. Thomas, Kerby A. Shedden, Rork Kuick, Jeremy M.G. Taylor, Sharon L.R. Kardia, David E. Misek, Thomas J. Giordano, Mark D. Iannettoni, Mark B. Orringer, Samir M. Hanash & David G. Beer. (2003) Overexpression of Oncoprotein 18 Correlates with Poor Differentiation in Lung Adenocarcinomas. Molecular & Cellular Proteomics 2:2, pages 107-116.
Crossref
Crossref
Lynne Cassimeris. (2002) The oncoprotein 18/stathmin family of microtubule destabilizers. Current Opinion in Cell Biology 14:1, pages 18-24.
Crossref
Crossref